1,393 results on '"Patrinos, George P."'
Search Results
2. Reforming the Past
3. Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
4. Meta-analysis of genomic variants in power and endurance sports to decode the impact of genomics on athletic performance and success
5. The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati population
6. Cost-effectiveness analysis of CYP3A5 genotype-guided tacrolimus dosing in solid organ transplantation using real-world data
7. Using ChatGPT to predict the future of personalized medicine
8. The Utility of CYP2D6 and CYP2C19 Variants to Guide Pharmacological Treatment in Complex Unipolar Major Depression: A Pilot Longitudinal Study
9. Triangulating nutrigenomics, metabolomics and microbiomics toward personalized nutrition and healthy living
10. Knowledge, attitudes, and perceptions of the multi-ethnic population of the United Arab Emirates on genomic medicine and genetic testing
11. Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics
12. Pharmacy students’ attitudes and intentions of pursuing postgraduate studies and training in pharmacogenomics and personalised medicine
13. Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response
14. A (hi)story of Horror
15. Clinical implementation of preemptive pharmacogenomics in psychiatry
16. Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study
17. Feasibility for pricing, budget allocation, and reimbursement of personalized medicine interventions
18. Assessing the stakeholder environment and views towards implementation of personalized medicine in a healthcare setting
19. Preface
20. Economic evaluation of personalized medicine interventions in medium- and low-income countries with poor proliferation of genomics and genetic testing
21. Economic analysis of pharmacogenetics testing for human leukocyte antigen-based adverse drug reactions
22. Theoretical models for economic evaluation in genomic and personalized medicine
23. Contributors
24. Foundations of pharmacogenomics and personalized medicine
25. Introduction to economic evaluation in health sciences
26. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
27. Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials
28. miRNAs as potential diagnostic biomarkers and pharmacogenomic indicators in psychiatric disorders
29. Do future healthcare professionals advocate for pharmacogenomics? A study on medical and health sciences undergraduate students
30. Clinical implementation of drug metabolizing gene-based therapeutic interventions worldwide
31. Artificial Intelligence/Machine Learning and Mechanistic Modeling Approaches as Translational Tools to Advance Personalized Medicine Decisions
32. Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment
33. Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates
34. Examining key factors impact on health science students’ intentions to adopt genetic and pharmacogenomics testing: a comparative path analysis in two different healthcare settings
35. J’Accuse….. Or The Plight of pro-bono Volunteer Scientists in Academic Publishing
36. A qualitative approach to assess the opinion of physicians about the challenges and prospects of pharmacogenomic testing implementation in clinical practice in Greece.
37. Pharmacogenomics: the low-hanging fruit in the personalized medicine tree
38. Preface
39. The genomic dimension in biodefense: Therapeutics
40. Pharmacogenomics in the Era of “Big Data” and Advanced Computational Approaches
41. Contributors
42. Investigating ABO Blood Groups and Secretor Status in Relation to SARS-CoV-2 Infection and COVID-19 Severity
43. Clinical implementation of preemptive pharmacogenomics in psychiatry
44. Fine-mapping genomic loci refines bipolar disorder risk genes
45. Assessing the utility of measurement methods applied in economic evaluations of pharmacogenomics applications
46. Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model
47. Economic evaluation in psychiatric pharmacogenomics: a systematic review
48. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology
49. Conference report: inaugural Pharmacogenomics Access & Reimbursement Symposium
50. Point-of-need molecular processing of biosamples using portable instrumentation to reduce turnaround time
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.